Kelly D Getz, PhD, MPH
Assistant Professor of Epidemiology in Biostatistics and Epidemiology
Assistant Professor of Epidemiology (tenure track), Perelman School of Medicine at The University of Pennsylvania
Investigator, Center for Real-world Evidence on the Effectiveness and Safety of Therapeutics (CREST), Perelman School of Medicine at The University of Pennsylvania
Senior Scholar, Center for Clinical Epidemiology & Biostatistics, Perelman School of Medicine at The University of Pennsylvania
Department: Biostatistics and Epidemiology
Contact information
423 Guardian Drive
909 Blockley Hall
Philadelphia, PA 19104
909 Blockley Hall
Philadelphia, PA 19104
Office: 215-746-1969
Email:
kgetz@pennmedicine.upenn.edu
kgetz@pennmedicine.upenn.edu
Publications
Education:
BS (Biology)
Millersville University, 1997.
MPH (Epidemiology)
Boston University School of Public Health, 2009.
PhD (Epidemiology)
Boston University School of Public Health, 2014.
Permanent linkBS (Biology)
Millersville University, 1997.
MPH (Epidemiology)
Boston University School of Public Health, 2009.
PhD (Epidemiology)
Boston University School of Public Health, 2014.
Description of Research Expertise
My research interests are broadly focused on the treatment and supportive care of children and young adults with cancer, with the goal of understanding and balancing therapeutic benefits and toxicity risks. I have a specific interest in the emerging field of cardio-oncology with a focus on earlier detection of the cardiotoxic side effects of cancer treatments, and mitigating cardiac disease as a barrier to effective cancer therapy. I also have an interest in identifying and reducing disparities in the treatment and outcomes of pediatric cancers.Selected Publications
Khuong QL†, Zheng DJ, Elgarten CE, Boulter AC, Aftandilian C, Bona K, Ghosh T, Gramatges MM, Huang YV, Maloney K, Mian A, Miller TP, Vasanna SH, Mody R, Myers R, Seif AE, Smith C, Stokke J, Winick NJ, Wilkes JJ, Wong V, Fisher BT, Ky B, Li Y, Aplenc A, Getz KD: Early cardiotoxicity and survival in pediatric acute myeloid leukemia: The mediating roles of relapse and salvage chemotherapy intensity. Blood 2025 (in press) Notes: Poster presentation at Annual meeting of the American Society of Hematology, December 2025. †Presenter is a primary mentee.Zheng DJ, Hettinger G, Bender JD, Boulter AC, Cao L, Elgarten CW, Fisher BT, Gathers C, Huang YV, Ko J, Leger KJ, Li Y, Myers MM, Narayan HK, Ortiz J, Seif SE, Vasileiadi E, Aplenc R, Getz KD: National trends in dexrazoxane and cardiovascular healthcare utilization for children with AML. JAMA Oncol 2025 (in press) Notes: Accepted Aug 2025.
Zheng DJ†, Khuong QL, Aftandilian C, Bona K, Boulter AC, Caywood E, Elgarten CE, Gathers C, Ghosh T, Gramatges MM, Henry M, Hettinger G, Huang YV, Li Y, Maloney K, Mian A, Miller TP, Mody R, Myers R, Ortiz J, Seif AE, Smith C, Stokke J, Vasanna SH, Winick NJ, Wilkes JJ, Wong V, Fisher BT, Aplenc A, Getz KD : Real-world post-relapse survival outcomes in children with Acute Myeloid Leukemia by race and ethnicity. Blood 2025 (in press) Notes: Oral presentation at Annual meeting of the American Society of Hematology, December 2025. †Presenter is a primary mentee.
Boulter AC†, Khuong QL, Zheng DJ, Jung W, Huang YV, Aftandilian C, Bona K, Elgarten CE, Ghosh T, Gramatges MM, Maloney K, Mian A, Miller TP, Mody R, Myers R, Seif AE, Smith C, Stokke J, Vasanna SH, Winick NJ, Wilkes JJ, Wong V, Fisher BT, Li Y, Aplenc A, Getz KD.: Influence of air quality on clinical acuity at presentation in pediatric patients with newly diagnosed acute myeloid leukemia. Blood 2025 (in press) Notes: Poster presentation at Annual meeting of the American Society of Hematology, December 2025. †Presenter is a primary mentee.
Zheng DJ†, Bhatia S, Mirzaei S, Aplenc R, Armstrong GT, Bona K, Brinkman TM, Brouwers P, Edelstein K, Getz K, Huang I, Kirchoff AC, Mostoufi-Moab S, Park ER, Snyder C, Yabroff KR, Yaui Y, Krull K, Nathan PC: Cumulative incidence of household material hardship and income loss as measures of financial toxicity during pediatric acute lymphoblastic leukemia (ALL) treatment: a report from the DFCI ALL16-001 trial. Blood 2025 (in press) Notes: Oral presentation at Annual meeting of the American Society of Hematology, December 2025. †Presenter is a primary mentee.
Dain AS, Li Y, Master S, Bailey C, Vossough A, Ichord R, Raffini L, Getz K*, Kwiatkowski JL*: Trends in hydroxyurea utilization and cerebrovascular outcomes before and after publication of the 2014 National Heart, Lung, and Blood Institute Sickle Cell Disease Guidelines. J Pediatr Hematol Oncol 2025 (in press) Notes: *Drs. Getz and Kwiatkowski contributed equally. Accepted for publication 20-Oct-2025.
Khuong QL†, Zheng DJ, Elgarten CE, Boulter AC, Aftandilian C, Bona K, Ghosh T, Gramatges MM, Huang YV, Maloney K, Mian A, Miller TP, Vasanna SH, Mody R, Myers R, Seif AE, Smith C, Stokke J, Winick NJ, Wilkes JJ, Wong V, Fisher BT, Ky B, Li Y, Aplenc A, Getz KD: Initiation of ACE inhibitors or beta-blockers during frontline therapy for pediatric acute myeloid leukemia and the impacts on cardiotoxicity incidence and survival outcomes: A target trial emulation. Blood 2025 (in press) Notes: Oral presentation at Annual meeting of the American Society of Hematology, December 2025. †Presenter is a primary mentee.
Vasileiadi E, Elgarten CW, Getz KD, Aplenc R, Fisher BT: Fluoroquinolone Susceptibility and Comparative Outcomes of Gram-negative Bloodstream Infection in Pediatric Patients with Hematologic Malignancy. J Pediatric Infect Dis Soc Oct 2025 Notes: doi: 10.1093/jpids/piaf091. Epub ahead of print.
Seif AE, McDonough SL, Becker-Haimes EM, Oranges KE, Clerico D, Hartman J, Rodock K, Schwartz LA, Elgarten CW, Myers RM, Puszczynski RO, Rheingold SR, Stern JW, Jubelirer TF, Armideo EA, Evageliou NF, Randall RJ, Bernt KM, Reilly AF, Tasian SK, Diamant RK, Fisher BT, Getz KD, Aplenc R: AML Care at Home: An Evidence-Based Toolkit to Personalize the Care Setting for Recovery From Pediatric AML Chemotherapy. JCO Oncol Pract Sep 2025 Notes: doi: 10.1200/OP-25-00314. Epub ahead of print.
Zheng DJ, Hettinger G, Aftandilian C, Bona K, Caywood EH, Collier AB, Elgarten CW, Gathers C, Ghosh T, Gramatges MM, Henry M, Huang YV, Li Y, Lotterman C, Maloney K, Mian A, Miller TP, Modi A, Mody R, Morgan E, Myers R, Newman H, Ortiz J, Seif AE, Smith C, Stokke J, Wang X, Winick N, Wilkes JJ, Wong V, Aplenc R, Getz KD: Real-world generalizability of clinical trial cytomolecular risk in pediatric acute myeloid leukemia: a report from the REAL-AML cohort. J Natl Cancer Inst Page: djaf234, Aug 2025 Notes: doi: 10.1093/jnci/djaf234. Epub ahead of print.